 | Up a level |
Nogova, Lucia, Sequist, Lecia V., Garcia, Jose Manuel Perez, Andre, Fabrice, Delord, Jean-Pierre, Hidalgo, Manuel, Schellens, Jan H. M., Cassier, Philippe A., Camidge, D. Ross, Schuler, Martin, Vaishampayan, Ulka 
ORCID: 0000-0001-5800-4571, Burris, Howard, Tian, G. Gary, Campone, Mario, Wainberg, Zev A., Lim, Wan-Teck ORCID: 0000-0002-4655-0206, LoRusso, Patricia, Shapiro, Geoffrey I., Parker, Katie, Chen, Xueying, Choudhury, Somesh, Ringeisen, Francois, Graus-Porta, Diana, Porter, Dale, Isaacs, Randi, Buettner, Reinhard and Wolf, Juergen
(2017).
Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study.
J. Clin. Oncol., 35 (2).
S. 157 - 176.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Sequist, Lecia V., Cassier, Phillippe, Varga, Andrea, Tabernero, Josep, Schellens, Jan H., Delord, Jean-Pierre, LoRusso, Patricia, Camidge, D. Ross, Hidalgo Medina, Manuel, Schuler, Martin, Campone, Mario, Tian, G. Gary, Wong, Steven, Corral, Jesus, Isaacs, Randi, Sen, Suman K., Porta, Diana Graus, Kulkarni, Swarupa G., Lefebvre, Caroline and Wolf, Juergen (2014). Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors. Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445